Advanced search
Publication Cover
Ocular Immunology and Inflammation Latest Articles
Submit an article Journal homepage
105
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Suprachoroidal Triamcinolone Injection in Posterior Scleritis: A Case Report

Ploysai Rujkorakarna Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USA;b Department of Ophthalmology, Suddhavej Hospital, Faculty of Medicine, Mahasarakham University, Maha Sarakham, ThailandORCID Iconhttps://orcid.org/0000-0003-4718-8744View further author information
, MDORCID Icon,
Avery Zhoua Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USAORCID Iconhttps://orcid.org/0000-0001-7436-0218View further author information
, MAORCID Icon,
Fatima Babikera Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USAORCID Iconhttps://orcid.org/0000-0002-8621-2471View further author information
, MDORCID Icon &
Peter Y. Changa Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USACorrespondence[email protected]
View further author information
, MD, FACS
Received 04 Mar 2023, Accepted 28 Jun 2023, Published online: 14 Jul 2023

References

  • Lagina A, Ramphul KS. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK499944/. Published June 27, 2022. Accessed February 21, 2023.
  • McCluskey PJ, Watson PG, Lightman S, Haybittle J, Restori M, Branley M. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106(12):2380–2386. doi:10.1016/S0161-6420(99)90543-2.
  • Foster CS, Kothari S, Anesi SD, et al. The ocular immunology and uveitis foundation preferred practice patterns of uveitis management. Surv Ophthalmol. 2016;61(1):1–17. doi:10.1016/J.SURVOPHTHAL.2015.07.001.
  • U.S. Food and Drug Administration. Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211950s000lbl.pdf. Accessed February 21, 2023.
  • Clearside Biomedical. XIPERE® (triamcinolone acetonide injectable suspension) for suprachoroidal use. https://www.xipere.com/hcp/. Accessed February 21, 2023.
  • Hancock SE, Wan CR, Fisher NE, Andino RV, Ciulla TA. Biomechanics of suprachoroidal drug delivery: from benchtop to clinical investigation in ocular therapies. Expert Opin Drug Deliv. 2021;18(6):777–788. doi:10.1080/17425247.2021.1867532.
  • Sen HN, Sangave AA, Goldstein DA, et al. A standardized grading system for scleritis. Ophthalmology. 2011;118(4):768–771. doi:10.1016/j.ophtha.2010.08.027.
  • Johnson KS, Chu DS. Evaluation of sub-tenon triamcinolone acetonide injections in the treatment of scleritis. Am J Ophthalmol. 2010;149(1):77–81. doi:10.1016/J.AJO.2009.07.035.
  • Sen HN, Vitale S, Gangaputra SS, et al. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 2014;121(11):2275–2286. doi:10.1016/J.OPHTHA.2014.05.021.
  • Leder HA, Jabs DA, Galor A, Dunn JP, Thorne JE. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol. 2011;152(3):441–448.e2. doi:10.1016/J.AJO.2011.02.009.
  • Zhao YJ, Zou YL, Lu Y, Tu MJ, You ZP. Intravitreal dexamethasone implant - a new treatment for idiopathic posterior scleritis: a case report. World J Clin Cases. 2021;9(2):422–428. doi:10.12998/WJCC.V9.I2.422.
  • Dubey N, Minija CK, Shanmugam MP. Intravitreal dexamethasone implant in a case of recurrent posterior scleritis. J Vitreoretin Dis. 2017;1(1):84–87. doi:10.1177/2474126416681324.
  • Ahn SJ, Hwang SJ, Lee BR. Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still’s disease: a case report. BMC Ophthalmol. 2016;16(1):1–4. doi:10.1186/S12886-016-0380-4.
  • Roufas A, Jalaludin B, Gaskin C, McCluskey P. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis. Br J Ophthalmol. 2010;94(6):743–747. doi:10.1136/BJO.2009.164962.
  • Sen HN, Ursea R, Nussenblatt RB, Buggage RR. Subconjunctival corticosteroid injection for the treatment of non-necrotising anterior scleritis. Br J Ophthalmol. 2005;89(7):917–918. doi:10.1136/BJO.2004.052738.
  • Tu EY, Culbertson WW, Pflugfelder SC, Huang A, Chodosh JC. Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology. 1995;102(5):718–724. doi:10.1016/S0161-6420(95)30963-3.
  • Yeh S, Khurana RN, Shah M, et al. Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial. Ophthalmology. 2020;127(7):948–955. doi:10.1016/J.OPHTHA.2020.01.006.
  • Khurana RN, Merrill P, Yeh S, et al. Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA). Br J Ophthalmol. 2022;106(8):1139–1144. doi:10.1136/BJOPHTHALMOL-2020-317560.
  • Henry CR, Shah M, Barakat MR, et al. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA). Br J Ophthalmol. 2022;106(6):802–806. doi:10.1136/BJOPHTHALMOL-2020-318019.
  • Kansara VS, Hancock SE, Muya LW, Ciulla TA. Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions. J Control Release. 2022;349:1045–1051. doi:10.1016/J.JCONREL.2022.05.061.
  • Habot-Wilner Z, Noronha G, Wykoff CC. Suprachoroidally injected pharmacological agents for the treatment of chorio-retinal diseases: a targeted approach. Acta Ophthalmol. 2019;97(5):460–472. doi:10.1111/AOS.14042.
  • Diogo MC, Jager MJ, Ferreira TA. CT and MR Imaging in the diagnosis of scleritis. AJNR Am J Neuroradiol. 2016;37(12):2334–2339. doi:10.3174/ajnr.A4890.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.